Intuitive Surgical gains 9% after releasing Q3 results 💡

Medical company Intuitive Surgical (ISRG.US), which is responsible for, among other things, the production of the innovative da Vinci surgical robots, is gaining nearly 9% on the stock market today, after the company's financial results for the third quarter of this year came in well above market expectations.

Highlights from the Q3 report:

• Adjusted earnings per share: $1.84 (estimate $1.64); +26% y/y
• Revenues: $2.04 billion (estimate $2 billion); +17% y/y
• Revenue from instruments and accessories: $1.26 billion (estimate $1.24 billion); +18% y/y
• Systems revenue: $445 million (vs. $379 million y/y); +17% y/y

Operating indicators:

• da Vinci procedures worldwide: +15% y/y
• Installed base of da Vinci surgical systems: 9539 systems (vs. 8285 y/y); +15%
• New da Vinci system deployments: 379 (vs. 312 y/y)
• da Vinci 5 systems: 110 units
• Operating leases: 220 systems, including 141 under usage-based leases

Business updates:

• Regulatory approval: received approval in South Korea for da Vinci 5 surgical system for multiple procedures (urology, thoracic, gynecological, etc.).

Cash and capital structure:

• Cash, cash equivalents and investments: $8.31 billion (up $628 million quarter-on-quarter)

The company's shares rocketed to new highs after the release of strong quarterly results. Source: xStation